首页 > 用药指导 > 文章详情

卡博替尼英文怎么写

发布时间:2023-07-11 17:45:17 阅读:86 来源:问药网
分享至

分享到微信朋友圈

×

打开微信,点击底部的“发现”,

使用“扫一扫”即可将网页分享至朋友圈。

卡博替尼

卡博替尼 生产厂家:美国Exelixis生物制药公司 功能主治:多种实体瘤的口服多靶点抑制剂,主治肝癌、肾癌等 用法用量:用法用量  推荐用量  1)分化型甲状腺癌:每次60mg,每日一次;  12岁以上儿科患者每次40mg,每日一次  2)肾癌:每次60mg,每日一次  3)肝癌:每次60mg,每日一次  服用方法  服用卡博替尼前至少2小时和后至少1小时不要进食
查看详情
  Phocabo20 is a kinase inhibitor that targets multiple receptors involved in tumor growth and angiogenesis, which is the process of forming new blood vessels to supply oxygen and nutrients to the tumor. By blocking these receptors, Phocabo20 inhibits the growth of cancer cells and the development of new blood vessels, thereby limiting the progression of the disease.
  The potential benefits of Phocabo20 are significant for patients with certain types of cancer. It has been approved for the treatment of advanced renal cell carcinoma (kidney cancer) and hepatocellular carcinoma (liver cancer) that cannot be surgically removed. It has also shown promising results in clinical trials for the treatment of other types of cancer, including medullary thyroid cancer and metastatic castration-resistant prostate cancer.
卡博替尼  One of the remarkable aspects of Phocabo20 is its ability to target multiple signaling pathways simultaneously. This means that it can potentially overcome resistance to other targeted therapies that only address one specific pathway. By targeting several receptors, Phocabo20 disrupts the tumor's ability to adapt and survive, making it a powerful option for patients who have failed previous treatments.
  While Phocabo20 offers hope to many patients, it is important to note that it is not without side effects. Common side effects include fatigue, diarrhea, nausea, loss of appetite, and high blood pressure. These side effects can often be managed with supportive care and medications. However, severe reactions, such as liver toxicity, bleeding, and gastrointestinal perforation, have been reported in some cases. Therefore, close monitoring by healthcare professionals is crucial throughout the treatment.
  As with any medication, Phocabo20 may interact with other drugs or have contraindications for certain medical conditions. It is essential for patients to inform their healthcare providers about any medications they are taking and their medical history to ensure the safe and effective use of this drug.
  In conclusion, Phocabo20 is a groundbreaking medication that offers new hope for patients with certain types of cancer. Its unique mechanism of action and ability to target multiple signaling pathways make it a promising treatment option. However, its use should be closely monitored due to potential side effects. It is recommended that patients consult with their healthcare providers to determine whether Phocabo20 is an appropriate treatment option for them.
美国Exelixis生物制药公司是一家致力于研发癌症小分子治疗的生物科技公司。该公司由科里·S·古德曼和斯特利奥斯·B·帕帕佐普洛斯于1994年11月15日创立,总部设在加利福尼亚州阿拉米达。
直达企业主页

热门文章

更多